Stay updated with breaking news from Naval Daver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KT-253 demonstrates initial clinical proof of concept in patients with tumor types shown to be sensitive in preclinical models, including responses in MCC and AML
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These adva
Operator: Good afternoon. My name is Jonathan and I will be your conference operator today.
Leading researchers in rare blood cancers to investigate new therapeutic strategy that targets leukemic stem cells.
Tuspetinib appears safe and effective when given alone or in combination with venetoclax in patients with relapsed/refractory AML. Tuspetinib appears safe and effective when given alone or in combination with venetoclax in relapsed/refractory AML.